EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Applying multilevel selection to understand cancer evolution and progression

Lucie Laplane, Anaïs Lamoureux, Harley I Richker, Gissel Marquez Alcaraz, Angelo Fortunato, Zachary Shaffer, Athena Aktipis, Paul S Mischel, Anya Plutynski, Jeffrey P Townsend, Carlo C Maley iD

PLOS Biology · 2025

DOI: 10.1371/journal.pbio.3003290 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Biology, 2025. Verfasst von Lucie Laplane und 10 weiteren Autor:innen. Beteiligte Einrichtung: UMR8590, CNRS & University Paris I Pantheon Sorbonne, Paris, France. Hauptthemen laut MEDLINE: Neoplasms, Selection, Genetic. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute, Centre National de la Recherche Scientifique.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural selection occurs at multiple levels of organization in cancer. At an organismal level, natural selection has led to the evolution of diverse tumor suppression mechanisms, while at a cellular level, it favors traits that promote cellular proliferation, survival and cancer. Natural selection also occurs at a subcellular level, among collections of cells and even among collections of organisms; selection at these levels could influence the evolution of cancer and cancer suppression mechanisms, affecting cancer risk and treatment strategies. There may also be cancer-like processes happening at different levels of organization, in which uncontrolled proliferation at lower levels may disrupt a higher level of organization. This Essay examines how selection operates across levels, highlighting how we might leverage this understanding to improve cancer research, prevention and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsSelection, GeneticAnimalsHumansBiological EvolutionCell ProliferationDisease Progression

Autor:innen und Institutionen

  • UMR8590, CNRS & University Paris I Pantheon Sorbonne, Paris, France.
  • UMR1270, Inserm & Gustave Roussy Cancer Campus, Villejuif, France.
  • Arizona Cancer Evolution Center, Arizona State University, Tempe, Arizona, United States of America.
  • Center for Evolution and Medicine, Arizona State University, Tempe, Arizona, United States of America.
  • Biodesign Center for Biocomputing, Security and Society, Arizona State University, Tempe, Arizona, United States of America.
  • School of Life Sciences, Arizona State University, Tempe, Arizona, United States of America.

ORCID-Profile: Carlo C Maley

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • Centre National de la Recherche Scientifique
  • Association pour la Recherche sur le Cancer
  • Cancer Research UK

Zitieren

APA

Laplane, L., Lamoureux, A., Richker, H. I., Marquez Alcaraz, G., Fortunato, A., Shaffer, Z., Aktipis, A., Mischel, P. S., Plutynski, A., Townsend, J. P., & Maley, C. C. (2025). Applying multilevel selection to understand cancer evolution and progression. PLOS Biology. https://doi.org/10.1371/journal.pbio.3003290

Vancouver

Laplane L, Lamoureux A, Richker HI, Marquez Alcaraz G, Fortunato A, Shaffer Z, et al. Applying multilevel selection to understand cancer evolution and progression. PLOS Biology. 2025. doi:10.1371/journal.pbio.3003290

BibTeX
@article{Laplane2025,
  author = {Laplane, Lucie and Lamoureux, Anaïs and Richker, Harley I and Marquez Alcaraz, Gissel and Fortunato, Angelo and Shaffer, Zachary and Aktipis, Athena and Mischel, Paul S and Plutynski, Anya and Townsend, Jeffrey P and Maley, Carlo C},
  title = {Applying multilevel selection to understand cancer evolution and progression},
  journal = {PLOS Biology},
  year = {2025},
  doi = {10.1371/journal.pbio.3003290}
}
Kostenlos starten →